Starting this year and for the next four years, NADFC will go into partnership with Japan International Cooperation Agency (JICA) to ensure the safety of pharmaceutical products and food products in Indonesia; one of them is concerning the activities of Pharmacovigilance. A series of activities to promote this project have been carried out. From 23 to 30 September, 2013 JICA once again gave supports to “Strengthening of Pharmacovigilance Activities” as the follow-up activities of the joint project. Several staff members of NADFC and Provincial office of NADFC were sent to Japan to learn and to observe directly the system of Japanese Pharmacovigilance and to get the positive points to be implemented in Indonesia. Those activities were participated by Director of Distribution Control of Therapeutic Product and Household Medical Supplies, the Chairman of Provincial Office of NADFC in Medan, the Chairman of Provincial Office of NADFC in Padang, the Chairman of Provincial Office of NADFC in Menado, Section Head of Surveillance of Therapeutic Product and Household Medical Supplies, and also staff members of Directorate of Distribution Control of Therapeutic Product and Household Medical Supplies and staff members of Directorate of Drug and Biological Product Evaluation.Read More
Pharmacovigilance program in Indonesia has been started and promoted by NADFC (National Agency for Drug and Food Control) as the national drug control authority. The main goal of pharmacovigilance program is not only to improve patient's safety of using drugs, but also to contribute towards the evaluation of benefit, danger, effectiveness and risks of using certain drugs, and also to encourage the safety, rationality, and effectiveness (including cost savings) of using drugs.
So far, the system that has been adopted in Indonesia concerning this activity is a spontaneous report delivered by health professionals using a yellow form which is a standard report of adverse drug reactions. It needs efforts to improve feedbacks because the reporting rate of spontaneous reporting system is still low compared to the number of population or the number of drugs distributed in Indonesia. To overcome these challenges, Indonesia has to strengthen they system and network of pharmacovigilance in all areas and healthcare facilities.
Based on what have been done, WHO once again offered its supports to NADFC to strengthen the program of pharmacovigilance in Indonesia by holding a workshop for health professionals with the theme of Strengthening Drug Safety Monitoring in Indonesia—National Pharmacovigilance Workshop from October 23 to October 25, 2017 in Bekasi. The workshop was attended by 135 participants consisting of hospitals and Community Health Centers in Sumatra, Java, and Bali, Health Department of DKI Jakarta (either Provincial Health Department or Public Health Service of DKI Jakarta), Health Department of Bekasi City, Health Department of Tanggerang City, and also Provincial Office of NADFC in Jakarta, Bandung, Semarang, Surabaya and Serang.Read More
In 2017, NADFC starts to conduct the supervision of the implementation of pharmacovigilance for HIV/AIDS, Tuberculosis, Malaria (ATM) drug programs. The supervision is conducted in order to implement Ministerial Decree of Ministry of Health Republic of Indonesia Number HK.02.02/ Menkes/164/2015 Date of April 30, 2015 on the Tryout of Pharmacovigilance for HIV/AIDS, Tuberculosis, Malaria (ATM) drugs at Healthcare service facilities. Those Healthcare service facilities conducting the tryouts according to the Decree are as follow:
A. DKI JAKARTARead More
Pada tanggal 21 Agustus 2017, untuk kali ketiga Badan POM menyelenggarakan Workshop/Peningkatan Kompetensi Farmakovigilans bagi Tenaga Kesehatan di Rumah Sakit Pendidikan yaitu RS Universitas Sumatera Utara (USU), Medan. Kegiatan ini dihadiri oleh high level management RS USU (Direktur Utama dan Direktur Pelayanan Medik & Keperawatan) dan tenaga kesehatan (dokter, apoteker, perawat) dari RS USU serta Kepala Balai Besar POM di Medan dan 4 orang staf.Read More